Sea-Blue HistiocytosisSymptoms, Doctors, Treatments, Advances & More
Sea-Blue Histiocytosis Overview
Learn About Sea-Blue Histiocytosis
- Sea-Blue histiocytosis
- Histiocytosis, sea-blue
- Inherited Lipemic Splenomegaly
- Sea-Blue histiocyte disease
Duke University Hospital
Louis Diehl is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. Diehl is rated as an Experienced provider by MediFind in the treatment of Sea-Blue Histiocytosis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Diehl is board certified in American Board Of Internal Med, Internal Medicine , American Board Of Internal Med, Hematology/Oncology , and American Board Of Internal Med, Medical Oncology. Dr. Diehl is currently accepting new patients.
Duke Cancer Center
Carlos De Castro Iii is a Hematologist Oncology specialist and a Hematologist practicing medicine in Durham, North Carolina. Dr. De Castro Iii is rated as an Experienced provider by MediFind in the treatment of Sea-Blue Histiocytosis. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. De Castro Iii is board certified in American Board Of Internal Med, Internal Medicine. Dr. De Castro Iii is currently accepting new patients.
Ballad Health Medical Associates Oncology & Hematology
Tamara Musgrave is a Hematologist and an Oncologist practicing medicine in Bristol, Tennessee. Dr. Musgrave is rated as an Advanced provider by MediFind in the treatment of Sea-Blue Histiocytosis. She is also highly rated in 49 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Thrombocytopenia, Neuroendocrine Tumor, and Angiosarcoma. Dr. Musgrave is board certified in American Board Of Internal Medicine. Dr. Musgrave is currently accepting new patients.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center


